Glutamatergic neural connections between the prelimbic prefrontal cortex and nucleus accumbens appear to be responsible for co-morbid anxiety and OCD behaviors.
People with OCD reported a reduction in the symptoms within four hours of smoking cannabis, a new study reports.
Interpersonal sensitivity, obsessive compulsions, and the time per day spent using a cell phone are strong predictors of nomophobia, a condition defined as a fear of being away from smart technology.
Neuroimaging predicts whether a person with OCD will respond to stress-reduction therapy or exposure-based therapy best. Analyzing brain activity may help to provide tailored treatments to individuals suffering from OCD.
A group of neurons located in the basal ganglia appears to play a vital role in cognitive flexibility.
Comparing data from multiple neuroimaging studies, researchers found shared brain structural abnormalities between four psychiatric disorders, including schizophrenia and bipolar disorder. They also identified brain signatures unique to each condition.
Targeted deep brain stimulation may help treat obsessive-compulsive disorder.
The antipsychotic medication clozapine can trigger severe obsessive-compulsive symptoms (OCS) in patients. Adding aripiprazole can help manage clozapine-associated OCS.
People with OCD have six times higher Immuno-moodulin (Imood) expression that those without the disorder. Blocking Imood with the aid of an antibody reduced OCD-like behaviors in mouse models within a couple of days following treatment.
Those with obsessive-compulsive disorder (OCD) may place less trust in their previous experiences, increasing uncertainty, indecisiveness, and repetitive behaviors.
Those with 22q11.2 deletion syndrome had significantly lower brain volume, as well as lower volumes in specific structures, including the thalamus, hippocampus, and amygdala.
Exercise addiction is almost four times as common in those with eating disorders.
